quipazine has been researched along with gr 65630 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eglen, RM; Loury, DN; Michel, AD; Sharif, NA; Stefanich, E; Whiting, RL; Wong, EH | 1 |
| Bonhaus, DW; Eglen, RM; Lee, JA; Loury, DN; Wong, EH; Wu, I | 1 |
2 other study(ies) available for quipazine and gr 65630
| Article | Year |
|---|---|
Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Topics: Animals; Binding, Competitive; Cell Line; Cerebral Cortex; Imidazoles; Indoles; Kinetics; Ligands; Mice; Nervous System Neoplasms; Neuroblastoma; Paroxetine; Piperidines; Quipazine; Rats; Receptors, Serotonin; Serotonin Antagonists; Tumor Cells, Cultured | 1991 |
Different densities of 5-HT3 receptors are labeled by [3H]quipazine, [3H]GR 65630 and [3H]granisetron.
Topics: Animals; Binding, Competitive; Cerebral Cortex; Cricetinae; Granisetron; Guinea Pigs; Ileum; Imidazoles; In Vitro Techniques; Indoles; Male; Mice; Neuroblastoma; Quipazine; Rabbits; Rats; Serotonin Antagonists; Tumor Cells, Cultured | 1993 |